Gov’t to allocate P362M for Covid-19 genomic bio-surveillance | Inquirer News

Gov’t to allocate P362M for Covid-19 genomic bio-surveillance

By: - Reporter / @DYGalvezINQ
/ 12:16 PM February 04, 2021

MANILA, Philippines — The Philippine government will allocate P362 million for genomic bio-surveillance to strengthen the country’s efforts against Covid-19, Cabinet Secretary Karlo Nograles said Thursday.

It will be the Department of Health (DOH) that will “mobilize” its resources and invest in bio-surveillance on Covid-19, he said.

ADVERTISEMENT

“The conduct of whole genome sequencing and bioinformatics analysis of the virus will enable us to understand the evolution of the geographical and time scales,” he said in a press briefing.

FEATURED STORIES

Genomic bio-surveillance will also help assess the impact of specific mutations of Covid-19 on its viral properties such as infectiousness and virulence, Nograles added.

Genomic bio-surveillance will also be important for the country’s Covid-19 vaccination program.

“A better understanding of the virus and its possible mutations will enable us to implement a more responsive vaccination program and execute other existing health interventions and to prepare for future pandemics,” the Palace official said.

EDV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.